| 영문 | diuretics | 한글 | 이뇨제 |
|---|---|---|---|
| 설명 | Na+과 수분의 배설을 촉진시킴으로써 소변량을 증가시키는 약물을 이뇨제라 한다. 즉 소변의 양을 증가시키는 약물을 이뇨제라고 한다. 소변을 생성하는 과정은 크게 2가지로 대별된다. 소변은 콩팥에 약 100만개 존재하는 콩팥단위(nephron)이라는 기능의 단위에서 만들어지는데 이 콩팥단위은 토리와 뇨세관으로 이루어진다. 토리란 콩팥으로 들어오는 혈액을 걸러내는 곳으로 우선 이곳에서 일단 걸러진 것을 원뇨라고 한다. 뇨세관은 이 원뇨가 지나가는 곳으로 이 원뇨에서 신체에 필요한 성분은 다시 체내로 흡수하고 토리에서 걸러지지 않은 불순물을 분비하여 오줌을 만드는 역할을 하는 곳이다. 이뇨제의 작용기전은 역시 이 2가지 과정에 관계하는데 토리에서 걸러지는 원뇨의 양을 증가시키는 기전과 세뇨관에서 재흡수를 하는 과정에 관계하여 수분과 Na+의 재흡수를 억제하는 기전으로 크게 나눌 수가 있다. 전자의 메커니즘으로 작용하는 이뇨제로는 심장에서 나오는 혈액의 양을 증가시켜서 콩팥의 토리를 지나는 혈액양을 증가시켜 많은 혈액을 걸러서 많은 양의 원뇨를 만드는 강심이뇨제와 삼투압을 증가시키는 물질을 투여하여 토리에서 걸러지는 양을 늘이는 삼투성 이뇨제 등이 있다. 현재 일반적으로 사용되는 대부분의 이뇨제들은 후자에 속하는, 즉 콩팥뇨세관에 작용하는 것들이다. |
||
| 영문 | potassium | 한글 | 칼륨 |
|---|---|---|---|
| 설명 | 원소 기호 19번이고 K로 표시하는 화학적 원소로 세포 내액의 가장 많은 양이온이기도 하다. |
||
| IHSS(= HCMP) | Idiopathic Hypertrophic Subaortic Stenosis = Obstructive Idiopathic Hypertrophic Car... |
|---|---|
| PSMF | protein-sparing modified fast |
| PST | pancreatic suppression test; paroxysmal supraventricular tachycardia; penicillin, streptomycin, and ... |
| ECG | Electro-Cardio-Graphy(-Gram); 심전도 = EKG 1. Conducting System Structu... |
| K+ | Potassium; Electrolyte |
| NSS | Nephron-sparing surgery |
|---|---|
| PSMF | protein sparing modified fast |
| KATP | ATP dependent potassium |
| K(ATP) | ATP sensitive potassium |
| KATP channel | ATP sensitive potassium channel |
potency
relation (위치, 관계
| potassium sparing diuretics | Diuretic agents that, unlike most diuretics, retain potassium; examples are triamterene and amiloride. Often used together with diuretics that promote the loss of both sodium and potassium. Used in hypertension and in congestive heart failure. (05 Mar 2000) |
|---|
| partial face-sparing lipodystrophy | A syndrome beginning at puberty that resembles total lipodystrophy but is inherited as an autosomal or X-linked dominant form. (05 Mar 2000) |
|---|---|
| sparing action | The manner in which a nonessential nutritive component, by its presence in the diet, lowers the dietary requirement for an essential component; thus, nonessential l-cysteine spares essential l-methionine and nonessential l-tyrosine spares essential l-phenylalanine. Synonym: sparing phenomenon. (05 Mar 2000) |
| sparing phenomenon | The manner in which a nonessential nutritive component, by its presence in the diet, lowers the dietary requirement for an essential component; thus, nonessential l-cysteine spares essential l-methionine and nonessential l-tyrosine spares essential l-phenylalanine. Synonym: sparing phenomenon. (05 Mar 2000) |
| mercurial diuretics | Diuretic drugs containing organic mercury (e.g., Mercuhydrin) which promote substantial salt and water loss through the kidney. Among the first potent diuretic agents used in congestive heart failure, but now obsolescent. (05 Mar 2000) |
| diuretics | Agents that promote the excretion of urine through their effects on kidney function. (12 Dec 1998) |
| diuretics, mercurial | A group of organometallic compounds, now rarely used, that promote diuresis by inhibiting tubular reabsorption of sodium and chloride. (12 Dec 1998) |
| diuretics, osmotic | Diuretics that are filtered at the glomerulus and reabsorbed in the renal tubule only to a limited extent. They thus increase the amount of osmotically active solute in the urine and a corresponding increase in urine volume. These compounds also increase the osmolality of plasma, thereby increasing the diffusion of water from the intraocular and cerebrospinal fluids; they can be used for reducing the pressure and volume of these fluids. (12 Dec 1998) |
| diuretics, sulfamyl | Diuretics containing one or more sulfonamide groups. They are similar to the benzothiazide diuretics in their pharmacological actions, but differ chemically in the nature of the heterocyclic ring. (12 Dec 1998) |
| diuretics, thiazide | Diuretics characterised as analogs of 1,2,4-benzothiadiazine-1,1-dioxide. All have a common mechanism of action and differ primarily in the dose required to produce a given effect. They act directly on the kidney to increase the excretion of sodium chloride and water and also increase excretion of potassium ions. (12 Dec 1998) |
| osmotic diuretics | Drugs, such as mannitol, which by their osmotic effects retain water during urine formation and thus dilute electrolytes in the urine, making resorption less efficient; they promote the elimination of water and electrolytes in the urine. (05 Mar 2000) |
| alpha-phenoxyethylpenicillin potassium | A penicillin preparation that is stable in gastric acid and is rapidly but only partially absorbed from the gastrointestinal tract. Synonym: alpha-phenoxyethylpenicillin potassium, penicillin B. (05 Mar 2000) |
| alpha-phenoxypropylpenicillin potassium | A semisynthetic acid-stable penicillin that may be more effective than penicillin G. Synonym: alpha-phenoxypropylpenicillin potassium. (05 Mar 2000) |
| aluminum potassium sulfate | AlK(SO4)2;an astringent and styptic; also used in veterinary medicine for ulcerative stomatitis, leukorrhoea, and conjunctivitis. Synonym: potassium alum. (05 Mar 2000) |
| amoxicillin-potassium clavulanate combination | <chemical> A fixed-ratio combination of amoxicillin trihydrate, an aminopenicillin, and potassium clavulanate, a beta-lactamase inhibitor, used to treat broad-spectrum antibacterial infections, especially of resistant strains. Pharmacological action: antibiotics, combined, antibiotics, lactam, enzyme inhibitors. (12 Dec 1998) |
| antimony potassium tartrate | <chemical> Bis(mu-(2,3-dihydroxybutanedioato(4-)-o(1),o(2):o(3),o(4)))diantimonate(2-) dipotassium trihydrate, stereoisomer. A schistosomicide possibly useful against other parasites. It has irritant emetic properties and may cause lethal cardiac toxicity among other adverse effects. Pharmacological action: schistosomicides. Chemical name: Antimonate(2-), bis(mu-(2,3-dihydroxybutanedioato(4-)-O1,O2:O3,O4))di-, dipotassium, trihydrate, stereoisomer (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|